Method of characterizing ZDHHC1 DNA
Provided herein is technology relating compositions and methods for detecting tissue cell-specific DNA in blood or blood products from a subject of a subject having cancer. The technology also relates to use of tissue cell-specific DNAs as internal controls for methylation assays.
1. A method of producing an amplified product, the method comprising:
a) treating DNA from a blood or blood product sample with a bisulfite reagent to produce bisulfite-converted ZDHHC1 DNA;
b) amplifying a region of said bisulfite-converted ZDHHC1 DNA using a pair of primers complementary to primer binding sites within SEQ ID NO:27 and its complement, wherein in said amplifying, said primers hybridize to said primer binding sites and are extended to amplify a region of SEQ ID NO:27 bounded by the primer binding sites to produce amplified product having a sequence comprising a region of SEQ ID NO:27 that comprises or is complementary to one or more of SEQ ID NOS: 28, 29, 30, 31 and/or 32.
2. The method of claim 1 , further comprising a step of detecting the amplified product with a detection probe.
3. The method of claim 2 , wherein said detection probe comprises a reporter molecule.
4. The method of claim 2 , wherein said detection probe comprises a flap sequence.
5. The method of claim 3 , where said reporter molecule comprises a fluorophore.
6. The method of claim 2 , wherein said detecting the amplified product with said detection probe comprises use of a FRET cassette.
7. The method of claim 2 , wherein said detecting the amplified product with said detection probe comprises use of a FEN-1 endonuclease.
8. The method of claim 1 , wherein said blood product sample is plasma.
9. The method of claim 1 , wherein said pair of primers is selected from primers having sequences selected from SEQ ID NOS: 29, 30, and 32.